Publication

Bigley AB, Baker FL, Simpson RJ. 2018. Cytomegalovirus: an unlikely ally in the fight against blood cancers?. Clin Exp Immunol. 193:265–274. doi:10.1111/cei.13152.

Eshghi N, Garland LL, Nia E, Betancourt R, Krupinski E, Kuo PH. 2018. F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer. J Nucl Med Technol. 46:260–264. doi:10.2967/jnmt.117.204933.

Kerins MJ, Milligan J, Wohlschlegel JA, Ooi A. 2018. Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction. Cancer Sci. 109:2757–2766. doi:10.1111/cas.13701.

Kuo PH, Stuehm C, Squire S, Johnson K. 2018. Meningeal Lymphatic Vessel Flow Runs Countercurrent to Venous Flow in the Superior Sagittal Sinus of the Human Brain. Tomography. 4:99–104. doi:10.18383/j.tom.2018.00013.

Robbins ML, Karan A, López AM, Weihs KL. 2018. Naturalistically observing noncancer conversations among couples coping with breast cancer. Psychooncology. 27:2206–2213. doi:10.1002/pon.4797.

Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW. 2018. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. Pain. 159:1814–1823. doi:10.1097/j.pain.0000000000001278.

Menghrajani K, Boonstra PS, Mercer JA, Perkins C, Gowin KL, Weber AA, Mesa R, Gotlib JR, Wang L, Singer JW, et al. 2018 Sep. Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis. Leuk Lymphoma.:1–7. doi:10.1080/10428194.2018.1509315.

Smalls BL, Aroh A, McQuerry K, Adegboyega A, Schoenberg N, Hatcher J. 2018. Social support and breast cancer screening in rural Appalachia. Psychooncology. 27:2281–2288. doi:10.1002/pon.4828.

Peters TL, Tillotson J, Yeomans AM, Wilmore S, Lemm E, Jiménez-Romero C, Amador LA, Li L, Amin AD, Pongtornpipat P, et al. 2018. Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with Antitumor Activity. Clin Cancer Res. 24:4256–4270. doi:10.1158/1078-0432.CCR-17-3645.

Persky DO, Li H, Rimsza LM, Barr PM, Popplewell LL, Bane CL, Von Gehr A, LeBlanc M, Fisher RI, Smith SM, et al. 2018. A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806. Am J Hematol. 93:486–493. doi:10.1002/ajh.25010.

Malm SW, Amouzougan EA, Klimecki WT. 2018. Fetal bovine serum induces sustained, but reversible, epithelial-mesenchymal transition in the BEAS-2B cell line. Toxicol In Vitro. 50:383–390. doi:10.1016/j.tiv.2018.04.008.

Dellinger MT, Witte MH. 2018. Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions. Clin Exp Metastasis. 35:419–424. doi:10.1007/s10585-018-9907-9.

Hamann HA, Ver Hoeve ES, Carter-Harris L, Studts JL, Ostroff JS. 2018. Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum. Journal of Thoracic Oncology. 13(8):1062–1075. doi:10.1016/j.jtho.2018.05.014.

Glazer AM, Stratton D, Curiel-Lewandrowski C. 2018. Potential Underuse of the Sentinel Lymph Node Biopsy for High-Risk Squamous Cell Carcinoma of the Skin. JAMA Dermatol. 154:972–973. doi:10.1001/jamadermatol.2018.1807.

de la Vega MR, Chapman E, Zhang DD. 2018. NRF2 and the Hallmarks of Cancer. Cancer Cell. 34:21–43. doi:10.1016/j.ccell.2018.03.022.

Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen HD, Bastian D, Zhang M, Sofi MH, Chatterjee S, Hill EG, Mehrotra S, et al. 2018. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 128:2787–2801. doi:10.1172/JCI95407.

Lin A, Kupinski MA, Peterson TE, Shokouhi S, Johnson LC. 2018. Task-based design of a synthetic-collimator SPECT system used for small animal imaging. Med Phys. 45:2952–2963. doi:10.1002/mp.12952.

Stewart DB, Gaertner WB, Glasgow SC, Herzig DO, Feingold D, Steele SR. 2018. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018). Dis Colon Rectum. 61:755–774. doi:10.1097/DCR.0000000000001114.

Adamo SH, Ericson JM, Nah JC, Brem R, Mitroff SR. 2018. Mammography to tomosynthesis: examining the differences between two-dimensional and segmented-three-dimensional visual search. Cognitive Research: Principles and Implications. 3(1). doi:10.1186/s41235-018-0103-x.

Wilkinson EM, Ilhan ZE, Herbst-Kralovetz MM. 2018. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics. Maturitas. 112:53–63. doi:10.1016/j.maturitas.2018.03.012.

Calton CM, Kelly KR, Anwer F, Carew JS, Nawrocki ST. 2018. Oncolytic Viruses for Multiple Myeloma Therapy. Cancers (Basel). 10. doi:10.3390/cancers10060198.

Weinstein RS, Krupinski EA, Doarn CR. 2018. Clinical Examination Component of Telemedicine, Telehealth, mHealth, and Connected Health Medical Practices. Med Clin North Am. 102:533–544. doi:10.1016/j.mcna.2018.01.002.

Olek D, El-Ghamry MN, Deb N, Thawani N, Shaver C, Mutyala S. 2018. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions. Brachytherapy. 17:601–608. doi:10.1016/j.brachy.2018.01.002.

LoConte NK, Gershenwald JE, Thomson CA, Crane TE, Harmon GE, Rechis R. 2018 May. Lifestyle Modifications and Policy Implications for Primary and Secondary Cancer Prevention: Diet, Exercise, Sun Safety, and Alcohol Reduction. Am Soc Clin Oncol Educ Book.:88–100. doi:10.1200/EDBK_200093.

Łaniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, Herbst-Kralovetz MM. 2018. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 8:7593. doi:10.1038/s41598-018-25879-7.